LMNL
Price:
$8.5
Market Cap:
$38.37M
Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the treatment of idiopathic pulmonary, liver, cardiac, or skin fibrosis with fezagepras or related derivatives and respiratory diseases. It is also developing antagonist candidate programs, including G-protein coupled receptor 84 and Oxo-eicosanoid receptor 1, which are in preclinical stage. The company was formerly known as Prometic Life Sciences Inc. and ch...[Read more]
Industry
Biotechnology
IPO Date
2009-12-18
Stock Exchange
NASDAQ
Ticker
LMNL
According to Liminal BioSciences Inc.’s latest financial reports and current stock price. The company's current ROE is -73.35%. This represents a change of 954.00% compared to the average of -6.96% of the last 4 quarters.
The mean historical ROE of Liminal BioSciences Inc. over the last ten years is -88.20%. The current -73.35% ROE has changed -16.84% with respect to the historical average. Over the past ten years (40 quarters), LMNL's ROE was at its highest in in the December 2018 quarter at 181.88%. The ROE was at its lowest in in the March 2021 quarter at -546.52%.
Average
-88.20%
Median
-80.48%
Minimum
-528.75%
Maximum
345.15%
Discovering the peaks and valleys of Liminal BioSciences Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 130.69%
Maximum Annual ROE = 345.15%
Minimum Annual Increase = -2388.79%
Minimum Annual ROE = -528.75%
| Year | ROE | Change |
|---|---|---|
| 2022 | -79.86% | -24.44% |
| 2021 | -105.69% | -80.01% |
| 2020 | -528.75% | 130.69% |
| 2019 | -229.21% | -166.41% |
| 2018 | 345.15% | -483.69% |
| 2017 | -89.96% | 18.12% |
| 2016 | -76.16% | 69.40% |
| 2015 | -44.96% | -629.64% |
| 2014 | 8.49% | -110.47% |
| 2013 | -81.10% | -2388.79% |
The current ROE of Liminal BioSciences Inc. (LMNL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-238.10%
5-year avg
-119.67%
10-year avg
-88.20%
Liminal BioSciences Inc.’s ROE is greater than Freeline Therapeutics Holdings plc (-102.94%), less than Serina Therapeutics, Inc. (522.99%), less than AnPac Bio-Medical Science Co., Ltd. (1.14%), greater than LakeShore Biopharma Co., Ltd (-18.43%), greater than Allakos Inc. (-97.39%), greater than Angion Biomedica Corp. (-7534.48%), less than Marinus Pharmaceuticals, Inc. (105.28%), greater than Vincerx Pharma, Inc. (-308.66%), greater than Opus Genetics, Inc. (-366.68%), greater than Traws Pharma, Inc. (-142.11%),
| Company | ROE | Market cap |
|---|---|---|
| -102.94% | $28.28M | |
| 522.99% | $37.00M | |
| 1.14% | $26.97M | |
| -18.43% | $25.84M | |
| -97.39% | $29.74M | |
| -7534.48% | $30.11M | |
| 105.28% | $30.37M | |
| -308.66% | $62.81K | |
| -366.68% | $153.73M | |
| -142.11% | $11.25M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Liminal BioSciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Liminal BioSciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Liminal BioSciences Inc.'s ROE?
How is the ROE calculated for Liminal BioSciences Inc. (LMNL)?
What is the highest ROE for Liminal BioSciences Inc. (LMNL)?
What is the 3-year average ROE for Liminal BioSciences Inc. (LMNL)?
What is the 5-year average ROE for Liminal BioSciences Inc. (LMNL)?
How does the current ROE for Liminal BioSciences Inc. (LMNL) compare to its historical average?